Kindred Biosciences reported $420.53M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adma Biologics ADMA:US $ 150.03M 55.07M
Bayer BAYN:GR 46.18B 4.3B
Biocryst Pharmaceuticals BCRX:US $ 2.57B 239.02M
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Eli Lilly And LLY:US $ 221.02B 902.49M
Idexx Laboratories IDXX:US $ 52.91B 950.27M
Kindred Biosciences KIN:US $ 420.53M 198.33M
Merk MRK:US $ 190131.55M 6786.63M
Minerva Neurosciences NERV:US $ 74.34M 24.78M
Novavax NVAX:US $ 15.44B 289.68M
Phibro Animal Health PAHC:US $ 872.45M 297.3M
Zoetis ZTS:US $ 91.85B 3.38B